Pure Biologics S.A. (WSE:PUR)

Pure Biologics Balance Sheet

Financials in millions PLN. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	0.3	0.31	3.61	2.26	6.18	8.96
Short-Term Investments	-	-	-	4.92	26.75	-
Cash & Short-Term Investments	0.3	0.31	3.61	7.18	32.93	8.96
Cash Growth	53.65%	-91.32%	-49.76%	-78.20%	267.68%	-35.67%
Accounts Receivable	-0.19	0.23	0.02	0.15	0.05	0.02
Other Receivables	0.69	1.45	14.73	15.07	9.24	1.34
Receivables	0.5	1.67	14.75	15.22	9.29	1.35
Prepaid Expenses	0.02	0.02	0.03	0.02	0.03	0.02
Other Current Assets	0.9	0.1	3.22	1.76	0.77	2.71
Total Current Assets	1.72	2.11	21.6	24.17	43.02	13.04
Property, Plant & Equipment	0.12	0.13	3.7	8.42	3.45	4.88
Long-Term Investments	-	-	-	0.02	0.02	-
Other Intangible Assets	0.05	0.12	0.26	0.29	0.33	0.37
Long-Term Deferred Charges	-	-	-	0.11	0.39	0.65
Other Long-Term Assets	-	-0.01	-2.82	-	-	-
Total Assets	1.88	2.34	22.74	33.01	47.19	18.94
Accounts Payable	1.7	0.85	1.03	7.24	0.67	2.76
Accrued Expenses	0.61	0.41	0.92	1.64	0.08	1.49
Current Portion of Long-Term Debt	14.62	13.96	-	-	-	-
Current Portion of Leases	0.02	0.1	0.09	1.1	1.11	1.38
Current Unearned Revenue	0.2	-	4.81	2.79	3.68	12.23
Other Current Liabilities	2.77	0.14	1.15	0.08	0	0.15
Total Current Liabilities	19.91	15.46	7.99	12.83	5.55	18
Long-Term Debt	-	-	12.72	-	-	-
Long-Term Leases	0.14	-	0.13	1.77	2	3.63
Long-Term Unearned Revenue	-	-	-	0.07	0.11	0.15
Other Long-Term Liabilities	-0	-	-	-	0	0
Total Liabilities	20.06	15.46	20.85	14.71	7.7	21.83
Common Stock	0.41	0.38	0.33	0.23	0.23	0.17
Additional Paid-In Capital	99.84	98.85	90.57	75.31	70.89	16.82
Retained Earnings	-118.42	-112.36	-92.93	-57.24	-31.63	-19.87
Comprehensive Income & Other	0	0.02	3.92	0	-	0
Shareholders' Equity	-18.17	-13.12	1.89	18.3	39.49	-2.89
Total Liabilities & Equity	1.88	2.34	22.74	33.01	47.19	18.94
Total Debt	14.78	14.06	12.94	2.86	3.11	5.01
Net Cash (Debt)	-14.49	-13.75	-9.33	4.32	29.82	3.95
Net Cash Growth	-	-	-	-85.52%	654.64%	-53.78%
Net Cash Per Share	-3.74	-3.94	-2.93	1.92	13.42	2.39
Filing Date Shares Outstanding	4.08	3.75	3.33	2.25	2.25	1.65
Total Common Shares Outstanding	4.08	3.75	3.33	2.25	2.25	2.25
Working Capital	-18.2	-13.35	13.61	11.34	37.47	-4.96
Book Value Per Share	-4.45	-3.50	0.57	8.12	17.52	-1.28
Tangible Book Value	-18.22	-13.23	1.64	18.01	39.16	-3.26
Tangible Book Value Per Share	-4.46	-3.53	0.49	7.99	17.37	-1.45
Land	-	-	-	0.1	0.87	-
Machinery	-	0.54	11.25	11.95	10.95	9.88

Updated Nov 15, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.